STOCK TITAN

Haleon (NYSE: HLN) finalizes terms for $2.0B 2027 bond buyback

(Neutral)
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Haleon plc (HLN) reports that its wholly owned subsidiary Haleon US Capital LLC has set the pricing terms, expiration and results for a cash tender offer to repurchase any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027.

The company directs investors to a detailed announcement hosted by the London Stock Exchange and Haleon’s investor website, and notes that the full text has been submitted to the UK Financial Conduct Authority’s National Storage Mechanism for public inspection.

Positive

  • None.

Negative

  • None.
Notes Outstanding Subject to Tender Offer $1,999,350,000 Principal amount of 3.375% Fixed Rate Senior Notes due March 2027 targeted in cash tender offer
Coupon Rate on Notes 3.375% Fixed interest rate on Haleon US Capital LLC Senior Notes due March 2027
Maturity of Notes March 2027 Maturity date of the Fixed Rate Senior Notes subject to the cash tender offer
Commission File Number 001-41411 SEC file number associated with Haleon plc
Filing Month August 2026 Month of the Form 6-K report of foreign private issuer
Cash Tender Offer financial
"announces the pricing terms, expiration and results of the Cash Tender Offer"
A cash tender offer is a public proposal in which an individual or group offers to buy a set number of a company's shares directly from shareholders for a specified cash price during a limited time. It matters to investors because it gives a clear, immediate chance to sell shares at a known price — like a store offering to buy back items at a posted rate — and can affect the stock’s market price, ownership control and liquidity.
Fixed Rate Senior Notes financial
"$1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027"
Debt securities that pay a set interest rate over their life and rank ahead of other obligations for repayment if a borrower faces financial trouble. Think of them as a fixed-pay IOU where holders are first in line to be repaid; investors care because they offer predictable income and generally lower risk than junior debt, so their yield and credit priority affect return and safety in a company’s capital structure.
National Storage Mechanism regulatory
"available for inspection at the Financial Conduct Authority's National Storage Mechanism"
A national storage mechanism is an official, centralized electronic repository where companies and regulators file and keep required corporate documents such as prospectuses, financial statements and regulatory disclosures. For investors it is the authoritative public source to find and verify key papers — like using a government-run public archive or filing cabinet — so you can check the original documents for due diligence, compliance and to confirm claims made in news or marketing.
Distribution Restrictions regulatory
"Distribution Restrictions - United Kingdom in the tender offer announcement"
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

FAQ

What debt transaction did Haleon plc (HLN) announce in the August 2026 Form 6-K?

Haleon announced finalized pricing terms, expiration and results for a cash tender offer by Haleon US Capital LLC to repurchase any and all of its outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027, with full details in a separate published announcement.

Which securities are targeted in Haleon (HLN)’s cash tender offer?

The tender offer targets Haleon US Capital LLC’s outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027. Haleon describes these as the Notes subject to the cash tender offer, with detailed terms and results available in an external announcement linked for investors.

Who is the offeror in Haleon plc (HLN)’s cash tender offer for 2027 Notes?

The offeror is Haleon US Capital LLC, a wholly owned subsidiary of Haleon plc. Haleon identifies this entity as conducting the cash tender offer for the outstanding 3.375% Fixed Rate Senior Notes due March 2027 on behalf of the group.

Where can investors find full details of Haleon (HLN)’s tender offer pricing and results?

Haleon states that full details are in an announcement available via the London Stock Exchange’s RNS PDF link, on Haleon’s investor website, and in the UK Financial Conduct Authority’s National Storage Mechanism, where the unedited text has been submitted for inspection.

What contact information did Haleon plc (HLN) provide regarding the cash tender offer?

Haleon lists dedicated contacts for investors, media and treasury, including phone numbers for named individuals and email addresses such as investor-relations@haleon.com, corporate.media@haleon.com and cf-treasury@haleon.com for queries related to the tender offer and broader company matters.

What type of company is Haleon plc (HLN) as described in this filing?

Haleon describes itself as a consumer company focused on better everyday health, with brands such as Advil, Centrum, Sensodyne and Voltaren across six categories including Oral Health, Pain Relief, VMS, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
19 August 2026 - “Cash Tender Offer - Pricing, Expiration and Result”
99.2
19 August 2026 -  Cash Tender Offer - Pricing, Expiration and Result
 
 
 
99.1
 
 
Haleon plc: Announces Pricing Terms, Expiration and Results of its Cash Tender Offer for outstanding 2027 Notes
 
Note: This announcement is being released in accordance with DTR 6.3.10 R. In the United Kingdom, the Tender Offer was only available to relevant persons, as described under "Non-U.S. Distribution Restrictions - United Kingdom" in the tender offer announcement available at https://www.rns-pdf.londonstockexchange.com/rns/2411Q_1-2026-8-11.pdf.
 
19 August 2026: Haleon plc (the "Company" or "Haleon") (LSE/NYSE: HLN) today announces the pricing terms, expiration and results of the offer to buy back any and all of the outstanding $1,999,350,000 3.375% Fixed Rate Senior Notes due March 2027 (the "Notes") of Haleon US Capital LLC's (the "Offeror"), the Company's wholly owned subsidiary (the "Tender Offer").
 
The full announcement is available at http://www.rns-pdf.londonstockexchange.com/rns/3204R_1-2026-8-19.pdf.
 
The full announcement will also be available on the Haleon website www.haleon.com/investors, and has been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
 
Enquiries
 
Investors
Media
 
Jo Russell
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
 
Email: investor-relations@haleon.com
 
Email: corporate.media@haleon.com
 
 
Treasury
 
Mike Rowe
+44 7775 012365
 
Ben Checkland
+44 7823 370368
 
 
Email: cf-treasury@haleon.com
 
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as AdvilCentrumOtrivinPanadolparodontaxPolidentSensodyneTheraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: August 19, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

Filing Exhibits & Attachments

1 document